111 related articles for article (PubMed ID: 16019368)
1. Percutaneous administration of testosterone gel in postmenopausal women--a pharmacological study.
Nathorst-Böös J; Jarkander-Rolff M; Carlström K; Flöter A; von Schoultz B
Gynecol Endocrinol; 2005 May; 20(5):243-8. PubMed ID: 16019368
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS
J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024
[TBL] [Abstract][Full Text] [Related]
3. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
Shah S; Bell RJ; Savage G; Goldstat R; Papalia MA; Kulkarni J; Donath S; Davis SR
Menopause; 2006; 13(4):600-8. PubMed ID: 16837882
[TBL] [Abstract][Full Text] [Related]
4. Testosterone therapy for postmenopausal decline in sexual desire: implications of a new study.
Sarrel PM
Menopause; 2006; 13(3):328-30. PubMed ID: 16735927
[No Abstract] [Full Text] [Related]
5. Transdermal testosterone gel: pharmacokinetics, efficacy of dosing and application site in hypogonadal men.
Meikle AW; Matthias D; Hoffman AR
BJU Int; 2004 Apr; 93(6):789-95. PubMed ID: 15049991
[TBL] [Abstract][Full Text] [Related]
6. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido--effects on sexuality and psychological general well-being.
Nathorst-Böös J; Flöter A; Jarkander-Rolff M; Carlström K; Schoultz Bv
Maturitas; 2006 Jan; 53(1):11-8. PubMed ID: 16183220
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and acute safety of inhaled testosterone in postmenopausal women.
Davison S; Thipphawong J; Blanchard J; Liu K; Morishige R; Gonda I; Okikawa J; Adams J; Evans A; Otulana B; Davis S
J Clin Pharmacol; 2005 Feb; 45(2):177-84. PubMed ID: 15647410
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
9. Testosterone therapy for sexual dysfunction in postmenopausal women.
Hubayter Z; Simon JA
Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
[TBL] [Abstract][Full Text] [Related]
10. A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate.
Saad F; Gooren LJ; Haider A; Yassin A
J Androl; 2008; 29(1):102-5. PubMed ID: 17916569
[TBL] [Abstract][Full Text] [Related]
11. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women.
Archer JS; Love-Geffen TE; Herbst-Damm KL; Swinney DA; Chang JR
Menopause; 2006; 13(3):528-37. PubMed ID: 16735951
[TBL] [Abstract][Full Text] [Related]
12. Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo.
Flyckt RL; Liu J; Frasure H; Wekselman K; Buch A; Kingsberg SA
Menopause; 2009; 16(4):680-8. PubMed ID: 19325500
[TBL] [Abstract][Full Text] [Related]
13. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy.
Bednarek-Tupikowska G; Filus A; Kuliczkowska-Płaksej J; Tupikowski K; Bohdanowicz-Pawlak A; Milewicz A
Gynecol Endocrinol; 2006 Apr; 22(4):207-12. PubMed ID: 16723307
[TBL] [Abstract][Full Text] [Related]
14. Oral testosterone in oil: pharmacokinetic effects of 5alpha reduction by finasteride or dutasteride and food intake in men.
Amory JK; Page ST; Bremner WJ
J Androl; 2006; 27(1):72-8. PubMed ID: 16400081
[TBL] [Abstract][Full Text] [Related]
15. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women.
Zang H; Carlström K; Arner P; Hirschberg AL
Fertil Steril; 2006 Jul; 86(1):136-44. PubMed ID: 16750207
[TBL] [Abstract][Full Text] [Related]
17. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.
Davis SR; Goldstat R; Papalia MA; Shah S; Kulkarni J; Donath S; Bell RJ
Menopause; 2006; 13(1):37-45. PubMed ID: 16607097
[TBL] [Abstract][Full Text] [Related]
18. Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Bérubé R; Bélanger P; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):897-906. PubMed ID: 19436226
[TBL] [Abstract][Full Text] [Related]
19. Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome.
Saad F; Gooren L; Haider A; Yassin A
Andrologia; 2008 Feb; 40(1):44-8. PubMed ID: 18211301
[TBL] [Abstract][Full Text] [Related]
20. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
